HIV and renal cell carcinoma: Experience in an Australian statewide HIV center.

about

HIV and renal cell carcinoma: Experience in an Australian statewide HIV center.

Item

http://www.wikidata.org/entity/Q39903015

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

HIV and renal cell carcinoma: Experience in an Australian statewide HIV center.

@en

HIV and renal cell carcinoma: Experience in an Australian statewide HIV center.

@nl

type

Item

label

HIV and renal cell carcinoma: Experience in an Australian statewide HIV center.

@en

HIV and renal cell carcinoma: Experience in an Australian statewide HIV center.

@nl

prefLabel

HIV and renal cell carcinoma: Experience in an Australian statewide HIV center.

@en

HIV and renal cell carcinoma: Experience in an Australian statewide HIV center.

@nl

P1476

HIV and renal cell carcinoma: Experience in an Australian statewide HIV center.

@en

P2093

Katherine King

http://www.w3.org/2001/XMLSchema#string

Mitchell Chipman

http://www.w3.org/2001/XMLSchema#string

Peter Royce

http://www.w3.org/2001/XMLSchema#string

Tze Lui Koh

http://www.w3.org/2001/XMLSchema#string

P2860

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

Global cancer statistics, 2012

A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061.

Increased prevalence of renal cell carcinoma in patients with HIV infection.

Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis.

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis.

Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies.

Cancer burden in the HIV-infected population in the United States

B cell responses to HIV antigen are a potent correlate of viremia in HIV-1 infection and improve with PD-1 blockade

Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis

P304

188-193

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AJCO.12487

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jeremy Millar

Wee Loon Ong

Jennifer Hoy

P577

2016-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26997617

http://www.w3.org/2001/XMLSchema#string

P921

HIV